This most up-to-date twist within the Lykos Therapeutics saga threatens A significant overhaul of the organization’s method and direction, with Musk ally and billionaire Trader Antonio Gracias appearing to desire to take the corporation back again towards its nonprofit drug improvement roots and a far more Doblinite philosophy.Disclaimer: copyrig